Cosmos Health Inc. (COSM) vs Estrella Immunopharma, Inc. (ESLA)
A side-by-side comparison of Cosmos Health Inc. and Estrella Immunopharma, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
COSM
Cosmos Health Inc.
$0.35HealthcareDelayed quote: Oct 6, 2026, 10:05 AM EDT
ESLA
Estrella Immunopharma, Inc.
$0.46HealthcareDelayed quote: Oct 6, 2026, 10:04 AM EDT
Total return — COSM vs ESLA
growth of $100 · dividends reinvested · last 5yCOSM -99.7% (-68.9%/yr)ESLA -95.5% (-46.2%/yr)ESLA compounded faster over this window
Log scale — wide-divergence pair
COSM ESLA
COSM vs ESLA: by the numbers
- •ESLA is the larger company ($19M vs $19M market cap).
- •Both run net losses; ESLA's is the smaller (0.00% vs -33.08% net margin).
Metrics side by side
Valuation
| Metric | COSM | ESLA |
|---|---|---|
| P/S ratio | 0.26 | N/A |
| P/B ratio | 0.92 | N/A |
Profitability
| Metric | COSM | ESLA |
|---|---|---|
| Gross margin | 10.27% | 0.00% |
| Operating margin | -24.65% | 0.00% |
| Net margin | -33.08% | 0.00% |
| ROE | -117.98% | N/A |
| ROIC | -46.69% | N/A |
Growth (annualized)
| Metric | COSM | ESLA |
|---|---|---|
| Revenue CAGR (5Y) | 5.24% | N/A |
| Total return CAGR (5Y) | -68.41% | -46.34% |
Frequently asked
- How have COSM and ESLA total returns compared?
- Over the past 5 years, COSM delivered -68.41% and ESLA delivered -46.34% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.